Eric Pierre Alexandre Arnoult

This inventor holds 13 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents. Top assignees: Janssen Sciences Ireland Uc, Janssen Sciences Ireland Unlimited Company, Janssen Pharmaceutica Nv. Active years: 2014-2023.

USPTO Granted Patents = 13

% Patents Active = 76.9

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 27(Granted Patents)

Company Filing History:

6 out of 111

Janssen Sciences Ireland Uc

patents

5 out of 64

Janssen Sciences Ireland Unlimited Company

patents

1 out of 2,099

Janssen Pharmaceutica Nv

Years Active: 2014-2023

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11702426 - Macrocyclic deaza-purinones for the treatment of viral infections (2023-07-18),

2. 10829494 - Macrocyclic deaza-purinones for the treatment of viral infections (2020-11-10),

3. 10822349 - Macrocyclic purines for the treatment of viral infections (2020-11-03),

4. 10526331 - Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2020-01-07),

5. 10501463 - Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2019-12-10),

6. 10280180 - Macrocyclic purines for the treatment of viral infections (2019-05-07),

7. 10266543 - Macrocyclic deaza-purinones for the treatment of viral infections (2019-04-23),

8. 10155759 - Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2018-12-18),

9. 9884864 - Antibacterial cyclopenta[C]pyrrole substituted 3,4-Dihydro-1H-[1,8]naphthyridinones (2018-02-06),

10. 9617262 - Antibacterial cyclopental[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2017-04-11),

11. 9290493 - Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2016-03-22),

12. 8906923 - Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2014-12-09),

13. 8898047 - Methods for identifying inhibitors against viruses that use a class I fusion protein (2014-11-25),

Title: Inventor Eric Pierre Alexandre Arnoult

Introduction: Eric Pierre Alexandre Arnoult is a renowned inventor hailing from Le Vaudreuil, France. He has made significant contributions to the field of innovations and patents.

Latest Patents: Eric Pierre Alexandre Arnoult holds several patents in various industries, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his career, Eric Pierre Alexandre Arnoult has been recognized for his groundbreaking inventions that have revolutionized different sectors. His innovative spirit and dedication to creating solutions have earned him a stellar reputation in the inventor community.

Collaborations: Eric Pierre Alexandre Arnoult has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work with diverse teams and leverage collective knowledge has been instrumental in his success.

Conclusion: In conclusion, Eric Pierre Alexandre Arnoult stands as a visionary inventor whose passion for innovation continues to drive him towards creating impactful solutions that shape the future of technology and beyond.